1. Introduction {#sec1-marinedrugs-15-00212}
===============

The octocoral *Nephthea columnaris* (Studer, 1895) (family Nephtheidae, order Alcyonacea, class Anthozoa, phylum Cnidaria) comprises large quantities of terpenoid \[[@B1-marinedrugs-15-00212],[@B2-marinedrugs-15-00212]\] and steroid \[[@B3-marinedrugs-15-00212],[@B4-marinedrugs-15-00212]\] analogues, which often have complex structures and biological activities. In continuing studies of the constituents of *N. columnaris* collected from the southern waters off the coast of Taiwan, two new sterols, columnaristerols B (**1**) and C (**2**), and known analogues, 5,6-epoxylitosterol (**3**) and litosterol (**4**) \[[@B5-marinedrugs-15-00212]\] ([Figure 1](#marinedrugs-15-00212-f001){ref-type="fig"}), were obtained. Sterol **3** was found to inhibit the production of superoxide anions and release of elastase by human neutrophils.

2. Results and Discussion {#sec2-marinedrugs-15-00212}
=========================

Columnaristerol B (**1**) was obtained as a non-crystalline powder, and high-resolution electrospray ionization mass spectrum (HRESIMS) analysis revealed that **1** had a pseudomolecular peak at *m/z* 437.33918 (calcd. for C~28~H~46~O~2~ + Na, 437.33900), which established the molecular formula C~28~H~46~O~2~, indicating six degrees of unsaturation. Data from ^1^H NMR and distortionless enhancement of polarization transfer (DEPT) analyses and examination along with the molecular formula of the compound suggested that there were two exchangeable protons that required the presence of two hydroxyl groups. IR spectrum analysis showed a broad absorption at 3386 cm^−1^, which further confirmed that interpretation. Combined examination of the molecular formula, ^13^C NMR and DEPT data revealed the presence of 28 carbons in **1** ([Table 1](#marinedrugs-15-00212-t001){ref-type="table"}), including five methyls, nine sp^3^ methylenes, eight sp^3^ methines (including two oxymethines, δ~C~ 79.5 and 71.7), an exocyclic double bond (δ~C~ 156.8 and 106.0), a trisubstituted double bond (δ~C~ 140.6 and 121.6), and two sp^3^ quaternary carbons.

In addition, the ^1^H NMR spectrum ([Table 1](#marinedrugs-15-00212-t001){ref-type="table"}) exhibited five methyl signals at δ~H~ 1.04 (3H, d, *J* = 6.4 Hz), 1.03 (3H, d, *J* = 6.8 Hz), 1.02 (3H, d, *J* = 6.8 Hz), 1.02 (3H, s), and 0.72 (3H, s). As the trisubstituted double bond and exocyclic double bond accounted for two of the six degrees of unsaturation, the remaining four degrees of unsaturation were ascribed to the presence of a tetracyclic compound.

By ^1^H--^1^H correlation spectroscopy (COSY) of **1**, proton signal correlations between δ~H~ 1.09/δ~H~ 1.84 and 1.49/δ~H~ 3.51/δ~H~ 2.31 and 2.22; δ~H~ 5.35/δ~H~ 1.99 and 1.49/δ~H~ 1.36/δ~H~ 1.06/δ~H~ 1.71 and 1.49/δ~H~ 3.46; δ~H~ 1.36/δ~H~ 0.92/δ~H~ 1.64 and 1.21/δ~H~ 1.76 and 1.52/δ~H~ 1.44/δ~H~ 1.77/δ~H~ 1.64 and 1.14/δ~H~ 2.12 and 1.92; δ~H~ 1.77/δ~H~ 1.04; δ~H~ 2.23/δ~H~ 1.02; and δ~H~ 2.23/δ~H~ 1.03 established the proton sequences H~2~-1/H~2~-2/ H-3/H~2~-4, H-6/H~2~-7/H-8/H-9/H~2~-11/H-12, H-8/H-14/H~2~-15/H~2~-16/H-17/H-20/H~2~-22/H~2~-23, H-20/H~3~-21, H-25/H~3~-26, and H-25/H~3~-27, respectively ([Table 1](#marinedrugs-15-00212-t001){ref-type="table"}). These data, together with the key heteronuclear multiple bond coherence (HMBC) correlations from H~2~-4 to C-5, C-6, and C-10; from H-6 to C-4 and C-10; from H~2~-7 to C-5; from H-8 to C-10; from H~2~-11 to C-13; from H-12 to C-18; from H-14 to C-12, C-13, and C-18; from H-17 to C-12, C-13, and C-18; from H~3~-18 to C-12, C-13, C-14, and C-17; from H~3~-19 to C-1, C-5, C-9, and C-10; from H~2~-23 to C-24 and C-28; from H-25 to C-23, C-24, and C-28; from H~3~-26 to C-24; from H~3~-27 to C-24; and from H~2~-28 to C-24 enabled elucidation of the carbon skeleton of **1** ([Table 1](#marinedrugs-15-00212-t001){ref-type="table"}). Moreover, the planar structure of **1** was determined by comparison of the ^13^C NMR data with those of a known principal sterol, 24-methylenecholesterol (**5**) ([Figure 1](#marinedrugs-15-00212-f001){ref-type="fig"}) \[[@B5-marinedrugs-15-00212],[@B6-marinedrugs-15-00212]\].

The relative stereochemistry of **1** was established by comparison of NMR data with those of sterol **5** \[[@B5-marinedrugs-15-00212],[@B6-marinedrugs-15-00212]\] and from the interactions observed in the nuclear Overhauser effect spectroscopy (NOESY) experiment, which were corroborated by MM2 force field calculations, suggesting the most stable conformation to be as shown in [Figure 2](#marinedrugs-15-00212-f002){ref-type="fig"} \[[@B7-marinedrugs-15-00212]\]. The configurations at C-3 (δ~C~ 71.7), C-8 (δ~C~ 30.6), C-9 (δ~C~ 49.5), C-10 (δ~C~ 36.5), C-13 (δ~C~ 47.6), C-14 (δ~C~ 54.7), C-17 (δ~C~ 57.3), and C-20 (δ~C~ 33.4) in **1** were found to be similar to those of **5** (C-3, δ~C~ 71.7; C-8, δ~C~ 31.9; C-9, δ~C~ 50.1; C-10, δ~C~ 36.5; C-13, δ~C~ 42.3; C-14, δ~C~ 56.7; C-17, δ~C~ 56.0; C-20, δ~C~ 35.7) \[[@B5-marinedrugs-15-00212]\], (C-3, δ~C~ 71.84; C-8, δ~C~ 31.94; C-9, δ~C~ 50.17; C-10, δ~C~ 36.52; C-13, δ~C~ 42.31; C-14, δ~C~ 56.80; C-17, δ~C~ 56.04; C-20, δ~C~ 35.79) \[[@B6-marinedrugs-15-00212]\]. A key correlation map obtained from the NOESY experiment for **1** showed interactions between H-1α (δ~H~ 1.84)/H-3 (δ~H~ 3.51), H-1α/H-9 (δ~H~ 1.06), H-2α (δ~H~ 1.84)/H-3, H-8 (δ~H~ 1.36)/H~3~-18 (δ~H~ 0.72), H-8/H~3~-19 (δ~H~ 1.02), H-9/H-12 (δ~H~ 3.46), H-12/H-14 (δ~H~ 0.92), H-14/H-17 (δ~H~ 1.44), and H~3~-18/H-20 (δ~H~ 1.77) ([Figure 2](#marinedrugs-15-00212-f002){ref-type="fig"}). Thus, the hydroxyl groups at C-3 and C-12 should be positioned on the β-face according to modeling analysis \[[@B7-marinedrugs-15-00212]\]. The aforementioned findings clearly confirmed the structure of columnaristerol B (**1**).

HRESIMS of new metabolite columnaristerol C (**2**) suggested a molecular formula of C~28~H~46~O~3~, as analysis showed a signal at *m/z* 453.33366 (calcd. for C~28~H~46~O~3~ + Na, 453.33392); in addition, the presence of a hydroxyl group was determined, as the IR spectrum of **2** showed a band at ν~max~ 3331 cm^−1^. The existence of a tertiary methyl (δ~H~ 1.03), three secondary methyls (δ~H~ 1.04, 3H, d, *J* = 6.4 Hz; 1.02, 6H, d, *J* = 6.8 Hz), two oxymethines (δ~H~ 4.25, 1H, m; 3.53, 1H, m), and one oxymethylene (δ~H~ 4.00, 3.68, *J*~AB~ = 12.0 Hz) were identified from the ^1^H NMR data, and the presence of a trisubstituted double bond was revealed by NMR data at δ~H~ 5.38 (1H, m), and δ~C~ 140.9 (C) and 121.2 (CH) ([Table 2](#marinedrugs-15-00212-t002){ref-type="table"}). Combined analysis of the molecular formula and the resonances of the ^13^C NMR and DEPT spectra revealed that **2** contained 4 methyls, 10 sp^3^ methylenes (including 1 oxymethylene), 8 sp^3^ methines (including 2 oxymethines), 2 sp^3^ quaternary carbons, 1 sp^2^ methylene, 1 sp^2^ methine, and 2 sp^2^ quaternary carbons. Comparison of the NMR chemical shift values of **2** with those of 24-methylenecholesterol (**5**) \[[@B5-marinedrugs-15-00212],[@B6-marinedrugs-15-00212]\], as well as its HMBC cross-peaks from H~2~-18 to C-12, C-13, C-14, and C-17, and ^1^H--^1^H COSY correlations between the oxymethine proton signal at δ~H~ 4.25 (H-16)/δ~H~ 2.42 and 1.52 (H~2~-15) and δ~H~ 4.25 (H-16)/δ~H~ 1.20 (H-17), suggested that **2** may be a 16,18-dihydroxyl analogue of **5**. Finally, the structure of **2** was confirmed based on the NOESY correlations ([Figure 3](#marinedrugs-15-00212-f003){ref-type="fig"}) observed between H-3/H-4α, H-4β/H~3~-19, H-8/H~2~-18, H-8/H~3~-19, H-9/H-14, H-14/H-16, and H~2~-18/H-20.

Sterols **3** and **4** were identified as 5,6-epoxylitosterol (5β,6β-epoxyergost-24(28)-ene-3β,19-diol) and litosterol (ergosta-5,24(28)-diene-3β,19-diol), which had been previously isolated from the Okinawan soft coral *Litophyton viridis* \[[@B5-marinedrugs-15-00212]\]. To the best of our knowledge, this was the first time that these two marine-origin sterols had been obtained from *Nephthea columnaris*.

In vitro anti-inflammatory activity assays were performed using human neutrophils, and the results demonstrated that sterol **3** had inhibitory effects on the generation of superoxide anions and the release of elastase, with IC~50~ values of 4.60 and 3.90 μM, respectively, but sterol **4** displayed no anti-inflammatory effects ([Table 3](#marinedrugs-15-00212-t003){ref-type="table"}). Comparison with the structures and anti-inflammatory activities of sterols **3** and **4** implied that the presence of a 5β,6β-epoxy group enhanced the activity.

3. Experimental Section {#sec3-marinedrugs-15-00212}
=======================

3.1. General Experimental Procedures {#sec3dot1-marinedrugs-15-00212}
------------------------------------

Column chromatography was carried out using silica gel (230--400 mesh size; Merck, Darmstadt, Germany). TLC was performed on plates precoated with Kieselgel 60 (with fluorescent indicator 254, 0.25-mm-thick; Merck), and the spots on the plates were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. Normal-phase HPLC (NP-HPLC) was performed using a HPLC system equipped with a Hitachi L-7110 pump (Hitachi, Tokyo, Japan) and an injection port (7725; Rheodyne, Rohnert Park, CA, USA). A semi-preparative normal-phase column (25 cm × 21.2 mm, 5 μM, Ascentis Si, Cat.: 581515-U, Sigma-Aldrich, St. Louis, MO, USA) was employed. Reverse-phase HPLC (RP-HPLC) was performed using a system equipped with a Hitachi L-7100 pump, a photodiode array detector (Hitachi L-2455), an injection port (Rheodyne 7725) and a 250 × 21.2 mm column (5 μM, Luna RP-18e; Phenomenex Inc., Torrance, CA, USA) or a 250 × 10.0 mm column (5 μM; Ascentis C18 Cat.: 581343-U, Sigma-Aldrich). IR spectra were obtained using a spectrophotometer (Nicolet iS5 FT-IR; Thermo Scientific, Waltham, MA, USA). NMR spectra were recorded on a NMR spectrometer (Varian Mercury 400 MHz Plus system; Varian, Palo Alto, CA, USA) using the residual CHCl~3~ signal (δ~H~ 7.26 ppm) and CDCl~3~ signal (δ~C~ 77.1 ppm) as the internal standard for ^1^H NMR and ^13^C NMR, respectively. Coupling constants (*J*) are presented in Hz. ESIMS and HRESIMS were recorded using a mass spectrometer (7 Tesla SolariX FTMS system; Bruker, Bremen, Germany). Melting points of the natural products were determined using a Fargo apparatus (Panchum Scientific, Kaohsiung, Taiwan), and the values were uncorrected. Optical rotation values were measured using a digital polarimeter (Jasco P-1010; Japan Spectroscopic, Tokyo, Japan).

3.2. Animal Material {#sec3dot2-marinedrugs-15-00212}
--------------------

Specimens of the octocoral *N. columnaris* were collected by hand using scuba equipment off the coast of Southern Taiwan in February, 2012. The samples were stored in a −20 °C freezer immediately until extraction. A voucher specimen (NMMBA-TW-SC-12057) was deposited in the National Museum of Marine Biology and Aquarium, Taiwan \[[@B8-marinedrugs-15-00212]\].

3.3. Extraction and Isolation {#sec3dot3-marinedrugs-15-00212}
-----------------------------

Sliced bodies of *N. columnaris* (wet weight 800 g, dry weight 76.7 g) were extracted with a mixture of methanol (MeOH) and dichloromethane (DCM) (*v:v* = 1:1). The extract (25.1 g) was partitioned between ethyl acetate (EtOAc) and H~2~O. The EtOAc layer (7.35 g) was separated on silica gel and eluted with *n*-hexane/EtOAc (stepwise, *v:v* = 100:1 to 100% EtOAc) to yield 12 subfractions A--L. Fraction G was separated by silica gel column chromatography and then eluted with *n*-hexane/acetone (stepwise, *v:v* = 20:1 to 100% acetone) to afford 10 subfractions G1--G10. Fraction G5 was purified by NP-HPLC using a mixture of *n*-hexane/acetone (*v:v* = 3:1) to afford ten subfractions G5A--G5J. Fraction G5E was repurified by RP-HPLC using a mixture of acetonitrile/H~2~O (*v:v* = 80:20) to yield four subfractions G5E1--G5E4. Fraction G5E3 was repurified by RP-HPLC using a mixture of MeOH/H~2~O (*v:v* = 95:5 at a flow rate of 4.0 mL/min) to yield **1** (0.8 mg). Fraction I was separated by silica gel column chromatography and then eluted with *n*-hexane/EtOAc (stepwise, *v:v* = 100:1 to 100% EtOAc) to afford 15 subfractions I1--I15. Fraction I13 was purified by NP-HPLC using a mixture of *n*-hexane/acetone/DCM (*v:v:v* = 3:1:1) to afford 11 subfractions I13A--I13K. Fraction I13G was repurified by RP-HPLC using a mixture of MeOH/H~2~O/tetrahydrofuran (*v:v:v* = 90:9.5:0.5 at a flow rate of 2.0 mL/min) to yield **2** (0.7 mg). Fraction I13H was repurified by RP-HPLC using a mixture of MeOH/H~2~O (*v:v* = 80:20) to afford seven subfractions I13H1--I13H7. Fraction I13H7 was further separated by NP-HPLC using a mixture of *n*-hexane/EtOAC (*v:v* = 2:1) to afford three subfractions I13H7A--I13H7C. Fraction I13H7C was repurified by RP-HPLC using a mixture of MeOH/H~2~O (*v:v* = 95/5 at a flow rate of 4.0 mL/min) to yield **3** (1.3 mg) and **4** (5.1 mg), respectively.

Columnaristerol B (**1**): white powder; mp 143--144 °C; $\mathsf{\alpha}_{D}^{25}$ −200 (*c* 0.53, CHCl~3~); IR (neat) ν~max~ 3386 cm^−1^, 1643 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 1](#marinedrugs-15-00212-t001){ref-type="table"}); ESIMS: *m*/*z* 437 \[M + Na\]^+^; HRESIMS: *m*/*z* 437.33918 (calcd. for C~28~H~46~O~2~ + Na, 437.33900).

Columnaristerol C (**2**): white powder; mp 140 °C; $\mathsf{\alpha}_{D}^{25}$ +31 (*c* 0.22, CHCl~3~); IR (neat) ν~max~ 3331 cm^−1^, 1640 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 2](#marinedrugs-15-00212-t002){ref-type="table"}); ESIMS: *m*/*z* 453 \[M + Na\]^+^; HRESIMS: *m*/*z* 453.33366 (calcd. for C~28~H~46~O~3~ + Na, 453.33392).

5,6-Epoxylitosterol (**3**): white powder; mp 160--161 °C (ref. \[[@B5-marinedrugs-15-00212]\], mp 179--183 °C); $\mathsf{\alpha}_{D}^{25}$ +17 (*c* 0.07, CHCl~3~) (ref. \[[@B5-marinedrugs-15-00212]\], \[α\] D +3.8 (*c* 0.26, CHCl3)); IR (neat) ν~max~ 3386 cm^−1^, 1641 cm^−1^; ^1^H (CDCl~3~, 400 MHz) and ^13^C (CDCl~3~, 100 MHz) NMR data were found to be in complete agreement with previous reports \[[@B5-marinedrugs-15-00212]\]; ESIMS *m/z* 453 \[M + Na\]^+^.

Litosterol (**4**): white powder; mp 147--149 °C (ref. \[[@B5-marinedrugs-15-00212]\], mp 147.5--150 °C); $\mathsf{\alpha}_{D}^{25}$ −31 (*c* 0.26, CHCl~3~) (ref. \[[@B5-marinedrugs-15-00212]\], \[α\] D −25.8 (*c* 0.24, CHCl~3~)); IR (neat) ν~max~ 3419 cm^−1^, 1635 cm^−1^; ^1^H (CDCl~3~, 400 MHz) and ^13^C (CDCl~3~, 100 MHz) NMR data were found to be in complete agreement with previous reports \[[@B5-marinedrugs-15-00212]\]; ESIMS *m/z* 437 \[M + Na\]^+^

3.4. Molecular Mechanics Calculations {#sec3dot4-marinedrugs-15-00212}
-------------------------------------

Implementation of the MM2 force field \[[@B7-marinedrugs-15-00212]\] in ChemBio 3D Ultra software from Cambridge Soft Corporation (ver. 12.0, Cambridge, MA, USA) was used to create molecular models.

3.5. Generation of Superoxide Anions and Release of Elastase by Human Neutrophils {#sec3dot5-marinedrugs-15-00212}
---------------------------------------------------------------------------------

Human neutrophils were obtained from whole blood using the method of dextran sedimentation and Ficoll centrifugation. Measurements of superoxide anion generation and the release of elastase by neutrophils were carried out according to previously described procedures \[[@B9-marinedrugs-15-00212],[@B10-marinedrugs-15-00212]\]. Briefly, superoxide anion production was assayed by monitoring the superoxide dismutase-inhibitable reduction of ferricytochrome *c*. Elastase release experiments were performed using MeO--Suc--Ala--Ala--Pro--Valp--nitroanilide as the elastase substrate.

4. Conclusions {#sec4-marinedrugs-15-00212}
==============

In the present study, our further investigation of natural substances obtained by extraction of *N. columnaris* led to the isolation of two new sterols, columnaristerols B (**1**) and C (**2**), as well as two known sterols, 5,6-epoxylitosterol (**3**) and litosterol (**4**) \[[@B5-marinedrugs-15-00212]\]. Our results demonstrated that **3** possessed potential anti-inflammatory activity in a human neutrophil model. The findings suggested that continued investigation of interesting secondary metabolites together with potentially useful bioactive substances from *N. columnaris* is worthwhile to inform potential new drug development.
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HRESIMS, and 1D (^1^H NMR, ^13^C NMR, and DEPT spectra) and 2D (HSQC, ^1^H−^1^H COSY, HMBC, and NOESY spectra) NMR spectra of new compounds **1** and **2** are available online at [www.mdpi.com/1660-3397/15/7/212/s1](www.mdpi.com/1660-3397/15/7/212/s1).
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![Octocoral *N. columnaris* and structures of columnaristerols B (**1**), C (**2**), 5,6-epoxylitosterol (**3**), litosterol (**4**), and 24-methylenecholesterol (**5**).](marinedrugs-15-00212-g001){#marinedrugs-15-00212-f001}

![Computer-generated model of **1** using MM2 force field calculations and selected protons with key NOESY correlations. Red color: oxygen atom; gray color: hydrogen atom; black color: carbon atom; \*: relative configuration.](marinedrugs-15-00212-g002){#marinedrugs-15-00212-f002}

![Computer-generated model of **2** using MM2 force field calculations and selected protons with key NOESY correlations. Red color: oxygen atom; gray color: hydrogen atom; black color: carbon atom; \*: relative configuration.](marinedrugs-15-00212-g003){#marinedrugs-15-00212-f003}
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^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data and ^1^H--^1^H COSY and HMBC correlations for sterol **1**.

  Position   δ~H~ (*J* in Hz)                    δ~C~, Multiple   ^1^H--^1^H COSY          HMBC
  ---------- ----------------------------------- ---------------- ------------------------ ------------------------------------------
  1α/β       1.84 m; 1.09 m                      37.2, CH~2~      H~2~-2                   C-2, C-3, C-5, C-10, C-19
  2α/β       1.84 m; 1.49 m                      31.6, CH~2~      H~2~-1, H-3              C-3
  3          3.51 m                              71.7, CH         H~2~-2, H~2~-4           n\. o. ^a^
  4a/b       2.31 ddd (12.8, 4.8, 2.0); 2.22 m   42.1, CH~2~      H-3                      C-2, C-3, C-5, C-6, C-10
  5          \-                                  140.6, C         \-                       \-
  6          5.35 br d (5.2)                     121.6, CH        H~2~-7                   C-4, C-7, C-8, C-10
  7a/b       1.99 m; 1.49 m                      31.5, CH~2~      H-6, H-8                 C-5, C-6, C-8, C-9
  8          1.36 m                              30.6, CH         H~2~-7, H-9, H-14        C-7, C-9, C-10, C-13, C-14
  9          1.06 m                              49.5, CH         H-8, H~2~-11             C-7, C-11
  10         \-                                  36.5, C          \-                       \-
  11a/b      1.71 m; 1.49 m                      31.3, CH~2~      H-9, H-12                C-8, C-9, C-12, C-13
  12         3.46 ddd (10.8, 5.2, 4.4)           79.5, CH         H~2~-11                  C-18
  13         \-                                  47.6, C          \-                       \-
  14         0.92 m                              54.7, CH         H-8, H~2~-15             C-8, C-12, C-13, C-15, C-18
  15a/b      1.64 m; 1.21 m                      23.8, CH~2~      H-14, H~2~-16            C-8, C-14, C-16, C-17
  16a/b      1.76 m; 1.52 m                      24.4, CH~2~      H~2~-15, H-17            n\. o.
  17         1.44 m                              57.3, CH         H~2~-16, H-20            C-12, C-13, C-16, C-18, C-20, C-21, C-22
  18         0.72 s                              7.8, CH~3~       \-                       C-12, C-13, C-14, C-17
  19         1.02 s                              19.3, CH~3~      \-                       C-1, C-5, C-9, C-10
  20         1.77 m                              33.4, CH         H-17, H~3~-21, H~2~-22   C-16
  21         1.04 d (6.4)                        21.5, CH~3~      H-20                     C-17
  22a/b      1.64 m; 1.14 m                      33.4, CH~2~      H-20, H~2~-23            C-21
  23a/b      2.12 m; 1.92 m                      32.5, CH~2~      H~2~-22                  C-20, C-22, C-24, C-28
  24         \-                                  156.8, C         \-                       \-
  25         2.23 m                              33.8, CH         H~3~-26, H~3~-27         C-23, C-24, C-26, C-27, C-28
  26         1.02 d (6.8)                        21.8, CH~3~      H-25                     C-24, C-25, C-27
  27         1.03 d (6.8)                        22.0, CH~3~      H-25                     C-24, C-25, C-26
  28a/b      4.72 br s; 4.67 br s                106.0, CH~2~     \-                       C-23, C-24, C-25

^a^ n. o. = not observed.
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###### 

^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data and ^1^H--^1^H COSY and HMBC correlations for sterol **2**.

  Position   δ~H~ (*J* in Hz)               δ~C~, Multiple   ^1^H--^1^H COSY          HMBC
  ---------- ------------------------------ ---------------- ------------------------ ----------------------------------------
  1a/b       1.81 m, 1.01 m                 37.2, CH~2~      H~2~-2                   C-5
  2a/b       1.83 m, 1.48 m                 31.6, CH~2~      H~2~-1, H-3              n\. o. ^a^
  3          3.53 m                         71.7, CH         H~2~-2, H~2~-4           n\. o.
  4α/β       2.32 m, 2.21 m                 42.2, CH~2~      H-3                      C-3, C-5, C-6
  5          \-                             140.9, C         \-                       \-
  6          5.38 m                         121.2, CH        H~2~-7                   C-4, C-7, C-8, C-10
  7a/b       2.30 m, 1.69 m                 31.0, CH~2~      H-6, H-8                 C-5, C-6
  8          1.94 m                         27.6, CH         H~2~-7, H-9, H-14        C-14
  9          1.08 m                         50.5, CH         H-8, H~2~-11             C-19
  10         \-                             36.6, C          \-                       \-
  11         1.50 m                         21.4, CH~2~      H-9, H~2~-12             n\. o.
  12a/b      2.12 m, 1.17 m                 38.9, CH~2~      H~2~-11                  C-18
  13         \-                             46.4, C          \-                       \-
  14         1.14 m                         60.4, CH         H-8, H~2~-15             C-8, C-9, C-12, C-13, C-16, C-17, C-18
  15a/b      2.42 m, 1.50 m                 41.8, CH~2~      H-14, H-16               C-13, C-16, C-17
  16         4.25 m                         70.1, CH         H~2~-15, H-17            C-13, C-17
  17         1.20 m                         55.8, CH         H-16, H-20               C-13, C-15, C-18, C-20
  18a/b      4.00 d (12.0), 3.68 d (12.0)   62.8, CH~2~      \-                       C-12, C-13, C-14, C-17
  19         1.03 s                         19.4, CH~3~      \-                       C-1, C-5, C-9, C-10
  20         1.95 m                         34.9, CH         H-17, H~3~-21, H~2~-22   C-22
  21         1.04 d (6.4)                   19.2, CH~3~      H-20                     C-17, C-20, C-22
  22a/b      1.55 m, 1.17 m                 34.9, CH~2~      H-20, H~2~-23            n\. o.
  23a/b      2.10 m, 1.91 m                 30.7, CH~2~      H~2~-22                  C-20, C-22, C-24, C-28
  24         \-                             156.6, C         \-                       \-
  25         2.21 m                         33.8, CH         H~3~-26, H~3~-27         C-23, C-24, C-26, C-27, C-28
  26         1.02 d (6.8)                   21.9, CH~3~      H-25                     C-24, C-27
  27         1.02 d (6.8)                   22.0, CH~3~      H-25                     C-24, C-26
  28a/b      4.72 br s, 4.66 br s           106.0, CH~2~     \-                       C-23, C-25

^a^ n. o. = not observed.
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###### 

Inhibitory effects of sterols **1**--**4** on superoxide anion generation and elastase release by human neutrophils in response to fMet-Leu-Phe/Cytochalastin B.

  Compound           Superoxide Anions   Elastase Release
  ------------------ ------------------- ------------------
  **1**              \>10                \>10
  **2**              \>10                \>10
  **3**              4.60 ± 0.85         3.90 ± 0.88
  **4**              \>10                \>10
  **LY294002 ^b^**   1.94 ± 0.81         4.44 ± 0.72

^a^ Concentration necessary for 50% inhibition (IC~50~); results are presented as mean ± SEM (*n* = 3). ^b^ LY294002 (2-morpholin-4-yl-8-phenylchromen-4-one) was used as the reference compound.

[^1]: These authors contributed equally to this work.
